US 11566011
Highly purified pharmaceutical grade tasimelteon
granted A61PA61P25/20
Quick answer
US patent 11566011 (Highly purified pharmaceutical grade tasimelteon) held by VANDA PHARMACEUTICALS INC. expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P25/20